因良性前列腺增生接受手术患者的偶发前列腺癌:一个预测模型
该回顾性研究纳入三个学术中心2012至2022年接受良性前列腺增生手术的2452例患者,偶发前列腺癌(iPCa)率为10.0%,其中临床显著iPCa为49/247例(20.2%)。多变量分析显示年龄和前列腺特异性抗原密度(PSAD)是iPCa诊断的独立预测因素,联合年龄>72岁和PSAD>0.1 ng/ml/cm3时iPCa率为35.4%。
要点
- 2452例接受BPH手术患者中,iPCa率为10.0%(247例),临床显著iPCa为49/247例(20.2%)。
- 年龄和PSAD是iPCa诊断的独立预测因素,联合模型AUC为0.65。
- PSAD>0.1 ng/ml/cm3患者iPCa风险为23.4%(χ2=52.6;p<0.001),若同时年龄>72岁则风险升至35.4%(χ2=11.1,p=0.008)。
核心结论
- 年龄和PSAD是iPCa诊断的独立风险因素。
- 年龄>72岁联合PSAD>0.1 ng/ml/cm3与35.4%的iPCa率相关。
研究设计与样本
- 回顾性分析三个学术中心2012年至2022年接受BPH手术患者的医疗档案,排除术前已诊断前列腺癌者,最终纳入2452例。
主要发现
- 2452例患者中247例(10.0%)诊断为iPCa,其中49/247例(20.2%)为临床显著iPCa(grade group ≥2)。
- 多变量分析显示年龄和PSAD是iPCa诊断的独立预测因素。
- 包含年龄和PSAD的模型AUC为0.65。
- CHAID分析显示PSAD>0.1 ng/ml/cm3患者iPCa风险为23.4%(χ2=52.6;p<0.001)。
- 在上述患者中,年龄>72岁使iPCa风险增至35.4%(χ2=11.1,p=0.008)。
关键数值与推荐
- PSAD>0.1 ng/ml/cm3:iPCa风险23.4%(χ2=52.6;p<0.001)。
- 年龄>72岁且PSAD>0.1 ng/ml/cm3:iPCa率35.4%(χ2=11.1,p=0.008)。
- 包含年龄和PSAD的模型AUC为0.65。
临床怎么用
- 作者认为该模型可识别有风险的患者,并在手术前诊断其癌症,可能避免不必要或有害的操作。
局限性
- 研究主要受限于其回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Histopathological examination of surgical specimens for benign prostatic hyperplasia (BPH) can detect incidental prostate cancer (iPCa). The aim of our study was to develop a predictive model for iPCa diagnosis for patients for whom BPH surgery is being considered. METHODS: We conducted a retrospective analysis of medical files for patients who underwent BPH surgery in three academic centers between 2012 and 2022. Patients diagnosed with PCa before surgery were excluded. We calculated the global iPCa rate, and the clinically significant iPCa rate (grade group ≥2). Univariate and multivariable regression models were used to assess factors predictive of iPCa. The area under the receiver operating characteristic curve (AUC) was compared for each risk factor and for the global model. We used χ2 automated interaction detection (CHAID) for decision tree analysis. KEY FINDINGS AND LIMITATIONS: We included 2452 patients in the analysis, of whom 247 (10.0%) had iPCa, which was clinically significant in 49/247 cases (20.2%). Multivariable analysis revealed that age and prostate-specific antigen density (PSAD) were independent predictive factors for iPCa diagnosis. The AUC for a model including age and PSAD was 0.65. CHAID analysis revealed that patients with PSAD >0.1 ng/ml/cm3 had an iPCa risk of 23.4% (χ2 = 52.6; p < 0.001). For those patients, age >72 yr increased the iPCa risk to 35.4% (χ2 = 11.1, p = 0.008). Our study is mainly limited by its retrospective design. CONCLUSIONS AND CLINICAL IMPLICATIONS: Age and PSAD were independent risk factors for iPCa diagnosis. The combination of age >72 yr and PSAD >0.1 ng/ml/cm3 was associated with an iPCa rate of 35.4%. PATIENT SUMMARY: We performed a study to find predictors of prostate cancer for patients undergoing surgery for benign enlargement of the prostate. Our model can identify patients at risk, and diagnose their cancer before surgery. This could avoid unnecessary or harmful procedures.
引用
- Anract J, Klein C, Pinar U, et al. Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. Eur Urol Oncol. 2024. PMID: 39256094. doi:10.1016/j.euo.2024.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。